EE651 Evaluating the Cost-Effectiveness of Dabrafenib and Trametinib for the Treatment of Pediatric Patients With Low-Grade Glioma Requiring Systemic Treatment in England and Wales
Dec 1, 2024, 00:00
10.1016/j.jval.2024.10.931
https://www.valueinhealthjournal.com/article/S1098-3015(24)03794-X/fulltext
Title :
EE651 Evaluating the Cost-Effectiveness of Dabrafenib and Trametinib for the Treatment of Pediatric Patients With Low-Grade Glioma Requiring Systemic Treatment in England and Wales
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(24)03794-X&doi=10.1016/j.jval.2024.10.931
First page :
Section Title :
Open access? :
No
Section Order :
10423